Goserelin

Nursing times · 2006 · PMID:16440976
other public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

This paper reviews the use of goserelin, a gonadotropin-releasing hormone agonist, in the treatment of hormone-sensitive cancers and benign gynecological conditions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents, Hormonal Goserelin Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Breast Neoplasms Breast Neoplasms Endometriosis Endometriosis Female Goserelin Goserelin Humans Male Nurse's Role Patient Education as Topic Patient Selection Prostatic Neoplasms Prostatic Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-06T06:10:23.601157+00:00
pubmed
last seen: 2026-05-13T22:15:23.967219+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine